The ENHANCE (Effect of Combination Ezetimibe and High-Dose Simvastatin vs. Simvastatin Alone on the Atherosclerotic Process in Patients with Heterozygous Familial Hypercholesterolemia) trial results were released on Jan. 14, 2008.  Dr. Tedd Mitchell, president of Cooper Clinic, discusses results of the ENHANCE trial (which compared Vytorin to Zetia), and gives Cooper Clinic's recommendation of what to do if someone currently takes either of these medications.